0
Back To Top Jump Location
Sign In  | Cart
Left Shadow
Right Shadow
Clinical study |

Atrial fibrillation complicating the course of degenerative mitral regurgitation: Determinants and long-term outcome FREE

Francesco Grigioni, MD; Jean-François Avierinos, MD; Lieng H Ling, MBBS, MRCP; Christopher G Scott, MS; Kent R Bailey, PhD; A.Jamil Tajik, MD, FACC; Robert L Frye, MD, FACC; Maurice Enriquez-Sarano, MD, FACC
[+] Author Information

Dr. Grigioni was supported by a grant from the Mayo Foundation.Reprint requests and correspondence: Dr. Maurice Enriquez-Sarano, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905, USA.

American College of Cardiology Foundation

J Am Coll Cardiol. 2002;40(1):84-92. doi:10.1016/S0735-1097(02)01922-8
Published online

Objectives  The study was done to define the incidence, determinants and prognostic implications of onset of atrial fibrillation (AF) during follow-up of mitral regurgitation (MR) initially in sinus rhythm.

Background  The rates and clinical implications of AF in MR are undefined.

Methods  We analyzed the occurrence of AF under conservative management in two populations of patients with degenerative MR in sinus rhythm at diagnosis: 1) 360 patients (65 ± 13 years, 74% men) with MR due to flail leaflets; and 2) 89 residents of Olmsted County, Minnesota (67 ± 17 years, 56% men) with grade 3 or 4 MR due to simple mitral valve prolapse (MVP) diagnosed echocardiographically.

Results  In patients with MR due to flail leaflets, AF rates at 5 and 10 years were 18 ± 3% and 48 ± 6%, respectively, and the linearized rate was 5.0 ± 0.7% per year. Development of AF during follow-up was independently associated with high risk of cardiac death or heart failure (adjusted risk ratio 2.23, p = 0.025). The AF rate at 10 years was higher in patients ≥65 years (75 ± 10% vs. 24 ± 6%, p < 0.0001) and in those with baseline left atrial (LA) dimension ≥50 mm (67 ± 8% vs. 37 ± 9%, p < 0.001). In multivariate analysis, independent baseline predictors of AF were age and LA diameter (both p < 0.01). In patients with MR due to MVP, similar rates of AF (41 ± 7% vs. 44 ± 6% at nine years, p > 0.50) and predictors of AF (age and LA dimension, both p < 0.006) were noted.

Conclusions  In patients with degenerative MR in sinus rhythm at diagnosis, the incidence of AF occurring under conservative management is high and similar whether the cause of MR is flail leaflet or simple MVP. After onset of AF, an increased cardiac mortality and morbidity are both observed under conservative management. The risk of AF increases with advancing age and larger LA dimension. These data suggest that the clinical management of MR should take into account the high incidence, excess risk, and predictors of AF.

Figures in this Article
AF

atrial fibrillation

BMI

body mass index

BSA

body surface area

CHF

congestive heart failure

CI

confidence interval

EF

ejection fraction

LA

left atrium/atrial

LV

left ventricle/ventricular

MR

mitral regurgitation

MVP

mitral valve prolapse

NYHA

New York Heart Association

RR

risk ratio

Atrial fibrillation (AF) is the most common arrhythmia (1) and is associated with an adverse prognosis (23). Therefore, identifying predisposing factors for AF (46), with the aim of improving strategies for its primary prevention, is essential.

Valvular heart diseases are associated with AF in the population (35), with a high population-attributable risk (6), but the specific risk of AF attached to each valvular lesion has not been well delineated (7). Furthermore, long-term risks and baseline predictors of AF in patients who were in sinus rhythm at diagnosis are poorly defined.

Mitral regurgitation (MR) is of particular interest regarding the development of AF because MR is common (8), particularly in the elderly (8), who are also at high risk for AF (6), and because MR tends to produce left atrial (LA) enlargement, a possible precursor of AF (9). In previous studies of patients with MR, those with preoperative AF had a worse postoperative outcome than those in sinus rhythm (10). However, in patients conservatively managed, series of limited size reported a highly variable incidence of AF (7,1112). Furthermore, the predictors of onset of AF in patients diagnosed with MR in sinus rhythm and the implications of AF for outcome under conservative (medical) management remain uncertain. Therefore, because of these conflicting or insufficient data regarding AF complicating MR, the concept of AF prevention, which may be of great importance, lacks substantiation and has not been implemented in the current guidelines regarding surgical decision making (13).

Patients with degenerative MR either with flail leaflets (14) or with simple mitral valve prolapse (MVP) represent the largest subset of candidates for MR surgery in Western countries (15), and they are an important population in which to determine the incidence and impact on outcome of AF. Also, flail leaflets (1617) and more recently MVP (18) are reliably diagnosed by echocardiography, allowing long-term follow-up of large populations. Accordingly, in patients who were in sinus rhythm when degenerative MR was diagnosed, we examined the long-term incidence, predisposing factors and prognostic implications of the development of AF.

The design of the study was a retrospective collection of cases in which the diagnosis, clinical and echocardiographic characteristics and subsequent events were independently noted (prospectively) during normal clinical care.

Patient population

Two populations of patients with degenerative MR in sinus rhythm at diagnosis were eligible for the study. The first population included patients with MR due to flail leaflets first diagnosed by two-dimensional echocardiography between January 1, 1980, and December 31, 1994, at the Mayo Clinic (Rochester, Minnesota). To determine whether AF rates and implications are similar in other patients with degenerative MR, we analyzed a second population involving patients who: 1) had MR due to MVP diagnosed between 1989 and 1995; 2) were Olmsted County, Minnesota, residents at diagnosis; and 3) had MR grade 3 or 4/4 by standard Doppler methods (all had comprehensive Doppler and color-flow imaging). In both populations, patients who had papillary muscle rupture, ischemic MR with isolated annular dilation, previous valve surgery or associated aortic or congenital disease were excluded. Patients who subsequently were identified with associated coronary disease or underwent bypass grafting at valvular surgery were not excluded.

Clinical data were obtained from medical records, and follow-up was obtained through clinical records, postal survey and telephone calls to patients, relatives or physicians. Confirmation of AF was based on electrocardiograms (12), and no unsubstantiated episode of palpitation was considered AF. Causes of death were ascertained by contacting patients’ physicians and by examining death certificates and autopsy records. Associated medical conditions were assigned weights and summated as a modified comorbidity index (19).

Echocardiographic methods

Comprehensive two-dimensional echocardiography was performed (20). The diagnosis of flail leaflets was based on failure of leaflet coaptation, with rapid systolic movement of the flail segment into the LA (16,21). The diagnosis of MVP was based on current criteria, using long-axis views of the valve (18). Severity of MR was assessed semiquantitatively on a scale of 1+ to 4+ by Doppler echocardiography (2223). Left ventricular (LV) and LA dimensions were obtained by using M-mode echocardiography, guided by two-dimensional imaging. Ejection fraction (EF) was visually estimated in all cases and was combined with calculated values as previously reported (12,2425). Data were used unaltered from the original prospective echocardiographic data collection by means of electronic transfer.

Statistical analysis

Continuous variables are expressed as mean ± SD and categorical data as percentages. Group comparisons were performed with analysis of variance, standard t test, or chi-square test as appropriate. After diagnosis, event rates were estimated by the Kaplan-Meier method, expressed as mean ± SE, and linearized rates were calculated as gross estimates of the hazard of AF. The main end point was occurrence of AF under conservative management, which was analyzed by censoring at the time of mitral valve surgery if eventually performed. Therefore, in all patients the time after diagnosis during which patients remained medically treated or managed was the time at risk for AF whether they had subsequent surgery or not. Identification of baseline predictors of AF was based on univariate Cox proportional hazards analysis of candidate clinical, laboratory and echocardiographic variables, with associated risk expressed as risk ratio (RR) and 95% confidence interval (CI). To account for effect of gender, body size, height, weight, body mass index (BMI), body surface area (BSA) and LV and LA sizes were used as absolute values or were normalized to the mean of each gender group. Age, gender and variables with univariate p < 0.10 were then tested in a multivariate model. To determine the impact of follow-up AF on subsequent outcome (death or heart failure) under conservative (medical) management, a time-dependent AF variable was tested within multivariate models (including baseline predictors) for the specific event, censoring patients at surgery (if operated on). Comparison of event rates between groups employed the two-tailed log-rank test, and between observed and expected survival the one-tailed log-rank test was used. A p value of <0.05 was considered statistically significant.

Baseline characteristics
MR due to flail leaflets

From a cohort of 468 patients with the diagnosis made by echocardiography from 1980 through 1994, a total of 360 (aged 65 ± 13 years, 74% men) met eligibility criteria. At presentation, 209 of these patients (58%) were in New York Heart Association (NYHA) functional class I, 82 (23%) in class II, 52 (14%) in class III and 17 (5%) in class IV. Subsequently, 234 patients (65%) underwent surgery 2.1 ± 2.9 years after diagnosis. Of the patients initially in NYHA functional class III or IV, 55 underwent surgery; 14 were not operated on because all had improved clinically after receiving medical treatment (n = 14) and also were not surgical candidates (n = 4) or refused surgery (n = 2). The presumed cause of flail leaflet was idiopathic in 295 patients, infective endocarditis in 58 patients, trauma in 5 patients and miscellaneous causes in 2 patients. The LV systolic and diastolic diameters, EF and wall thickness were 35 ± 6 and 60 ± 7 mm, 64 ± 9% and 11 ± 1 mm, respectively. The LA diameter was 50 ± 8 mm. Among the 330 patients in whom MR was graded by Doppler echocardiography, 277 (84%) had grade 3+ or 4+/4+ regurgitation. Follow-up was complete for 357 patients (99%).

MR due to MVP

Among 645 residents of Olmsted County, Minnesota, diagnosed with MVP between 1989 and 1995, 89 had severe MR (grade 3 or 4) and were in sinus rhythm at diagnosis. Compared with patients with flail leaflets, those with MVP had similar age (67 ± 17 vs. 65 ± 13 years, p = 0.22), comorbidity (p = 0.38), NYHA functional class (III to IV in 19 vs. 19%, p = 0.90) and BMI (24.2 ± 4 vs. 24.5 ± 4, p = 0.50). However, patients with MVP had slightly lower EF (61 ± 11 vs. 64 ± 9%, p = 0.03), had smaller LA (46 ± 10 vs. 50 ± 8 mm, p = 0.002) and were more often women (44 vs. 26%, p = 0.02). During follow-up, 35 patients (39%) underwent surgery 3.7 ± 2.8 years after diagnosis.

Incidence of AF
MR due to flail leaflets

During follow-up under medical management (38 ± 40 months), 56 patients experienced AF and 304 remained in sinus rhythm. At 5 and 10 years, overall rates of AF were 18 ± 3% and 48 ± 6%, respectively (Figure 1). Yearly linearized rate of AF was 5.0 ± 0.7%. The mean time to occurrence of AF was 52 ± 32 months. The initial episode of AF was paroxysmal in 25 patients, representing a 10-year rate of 24 ± 5%, but subsequent recurrence was 49 ± 12% at 1 year and 56 ± 12% at 2 years. The first episode of AF was permanent in 31 patients. Accounting for recurrence of AF, the 10-year rate of permanent AF was 32 ± 6%. After surgery in the 234 patients, the total rate of AF was 6% at 3 months and 37 ± 5% at 10 years.

Grahic Jump Location
Figure 1

Incidence of atrial fibrillation (AFib) under conservative (medical) management among patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm. The overall rates of new atrial fibrillation and of permanent and paroxysmal atrial fibrillation are presented as Kaplan-Meier curves.

MR due to MVP

Under medical management, 19 patients incurred AF, with an incidence rate similar to that of patients with flail leaflets (at 9 years 41 ± 9% vs. 44 ± 6%, p = 0.67). When all 449 degenerative MR patients were combined, the 5-year and 10-year rates of AF were 18 ± 3% and 47 ± 5%, respectively. Of note, survival under conservative management was similar whether MR was due to MVP or flail leaflets (9-year, 61 ± 8 vs. 60 ± 5%; p = 0.70), with 5-year and 10-year survival under conservative management for all degenerative MR of 78 ± 3% and 52 ± 5%, respectively.

Determinants of AF
MR due to flail leaflets

For descriptive purposes, baseline characteristics of the patients who had AF under conservative management compared with those who remained in sinus rhythm under conservative management and with those who remained in sinus rhythm until they underwent mitral surgery are presented in (Table le1)(left panel). Although these groups were different globally, few variables were different between the group with AF and that with persistent sinus rhythm under conservative medical management (as opposed to the surgical group). In particular, age and LA size were different. Of note, a history of myocardial infarction was not observed with higher prevalence at diagnosis in patients who developed AF during conservative follow-up (Table le1). This result is consistent with the prevalence of coronary disease in the 191 patients who underwent coronary angiography at any point during follow-up (10/33 or 30% in patients with AF, 2/4 in patients without AF and followed conservatively and 45/154 or 30% in patients who remained in sinus rhythm until surgery [p = 0.69]). However, compared with all patients who remained in sinus rhythm, those who had AF remained under conservative management (instead of undergoing surgery) more often (at five years, 64 ± 6 vs. 37 ± 3%; p < 0.001) and for a longer time (2,162 ± 1,283 days from diagnosis vs. 1,062 ± 1,239 days, p < 0.0001).

Table Grahic Jump Location
Table 1Baseline Characteristics of Patients With MR Due to Flail Leaflets and Association With Subsequent Development of AF
Table Footer Note*Denotes p < 0.05 in comparison with patients in whom AF developed under conservative management.
Table Footer NoteTime to AF is for events occurring under conservative management. Continuous variables are expressed as mean ± SD and categorical variables as percentages.

Therefore, it is essential to analyze the end point of time to occurrence of AF under conservative management with the Cox proportional hazards method (Table le1, right panel). The baseline clinical predictors of time to AF were age (p < 0.0001) and comorbidity (p = 0.045), with borderline effect of female gender (p = 0.14). Incidence of AF was higher in patients ≥65 years versus <65 years (75 ± 10% vs. 24 ± 6% at 10 years, p < 0.0001, Figure 2). Yearly rates of AF in patients ≥65 years and <65 years were 6.9 ± 1.1% and 2.8 ± 0.7%, respectively (p < 0.0001).

Grahic Jump Location
Figure 2

Atrial fibrillation (AFib) rate in patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm, according to age at diagnosis, <65 or ≥65 years old (yo). Note the considerably higher rate in older patients.

The LA dimension was the only echocardiographic variable (p = 0.0004) predictive of time to AF. Of note, severe MR was neither more prevalent nor associated with shorter time to AF (Table le1). Incidence of AF was higher with LA dimension ≥50 mm versus <50 mm (at 10 years, 67 ± 8% vs. 37 ± 9%; p < 0.0001; Figure 3). Yearly rates of AF with LA ≥50 mm and <50 mm were 8.4 ± 1.6% and 2.9 ± 0.7%, respectively (p < 0.0001). The predictive power of uncorrected LA dimension was not improved by normalizing LA diameter by gender and was superior to that of the LA diameter normalized to BSA, which was only marginal (p = 0.08). The LV EF or diameters (normalized or not to BSA) showed no association with AF. Also, patients with and without MR grade 3 or 4 had similar rates of AF (at 10 years, 44 ± 7% vs. 49 ± 14%, respectively; p = 0.40).

Grahic Jump Location
Figure 3

Atrial fibrillation (AFib) rate in patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm, according to left atrial diameter at diagnosis <50 or ≥50 mm. Note the considerably higher rate in patients with a markedly dilated left atrium.

MR due to MVP

The only baseline predictors of AF were age and LA diameter, with RRs (age: RR [95% CI] = 1.05/year [1.03 to 1.07], p < 0.0001; LA diameter: 1.07/mm [1.04 to 1.10], p < 0.0001) very similar (p > 0.12) to those of patients with flail leaflet (Table le1, right panel).

Multivariate analysis

In MR due to flail leaflets, using original baseline variables, age and LA dimension were the only independent predictors of AF, and female gender showed a borderline trend (Table le2). Similarly, in the entire population of degenerative MR (combining flail leaflets and MVP), age ≥65 years and LA ≥50 mm were predictors of AF (Table le2) independently of gender. However, LA size was smaller in women than in men (47 ± 8 vs. 50 ± 9 mm, p = 0.007 overall), which may potentially bias the effect of LA size and gender on incidence of AF. Therefore, first, multivariate models were repeated separately in men and women. In both genders, adjusting for age, the absolute LA size (adjusted RR = 3.17 and 1.73 per 10-mm increment, p < 0.0001 and p = 0.007 in women and in men, respectively) was independently predictive of AF.

Table Grahic Jump Location
Table 2Multivariate Predictors of Atrial Fibrillation

Second, multivariate analysis was repeated in the entire population using LA diameter normalized to gender, showing that age and LA remained independently predictive of AF incidence (Table le2) and that gender was not associated with AF after diagnosis. Symptoms, comorbidity, history of myocardial infarction, all risk factors for coronary disease and cause of degenerative MR (MVP vs. flail leaflets) were not independently predictive of AF (all p > 0.40).

Impact of onset of AF on mortality and morbidity

In MR due to flail leaflets, during conservative follow-up 67 deaths (44 [66%] cardiovascular) occurred. At 10 years, the observed survival rate was lower than the expected survival of the general population of same age and gender (53 ± 5% vs. 64%, p = 0.051). Using time-dependent analysis, onset of AF during follow-up was associated with an increased risk of subsequent death (RR = 3.42, 95% CI = 1.7 to 6.7, p < 0.0001). Multivariate analysis confirmed that new AF during follow-up was independently (of age, NYHA functional class at baseline and EF) associated with increased mortality (adjusted RR = 2.02, p = 0.056) (Figure 4).

Grahic Jump Location
Figure 4

Survival of patients with mitral regurgitation due to flail leaflets adjusted for age, gender, ejection fraction and symptoms at baseline, and separating at the fourth year after diagnosis those patients with and those without postdiagnosis atrial fibrillation. Note the excess mortality in patients with follow-up atrial fibrillation. SR = sinus rhythm; AF = atrial fibrillation; F-U = follow-up.

Similarly, 78 patients with flail leaflets experienced congestive heart failure (CHF) under conservative management. Onset of new AF during follow-up was associated with a higher risk of CHF (RR = 3.23, 95% CI = 1.59 to 6.58, p = 0.001). In multivariate analysis, new AF was independently (adjusting for baseline age, NYHA functional class and EF) associated with CHF (adjusted RR = 2.26, p = 0.032) whether AF was initially permanent or paroxysmal (p = 0.09). Rates of cardiac death and CHF at 5 and 10 years were 31 ± 3% and 59 ± 5%, respectively, and were independently higher after new AF (adjusted RR = 3.13, p = 0.0009). When examined in all patients with degenerative MR, AF during follow-up remained associated with higher rate of subsequent CHF (adjusted RR [95% CI] = 4.85 [2.89 to 8.14], p < 0.0001) and of CHF or cardiac death (adjusted RR [95% CI] = 4.37 [2.74 to 6.97], p < 0.001).

The present study shows that AF is a common complication in patients with degenerative MR while they are conservatively managed, occurring at a linearized rate of 5% per year. The incidence of AF is similar whether MR is due to flail leaflets or MVP. The onset of AF is independently associated with an increased risk of adverse cardiac death and heart failure. With advancing age, the risk of AF increases markedly. The LA dimension in sinus rhythm is also a major independent predictor of subsequent AF under conservative management. The high frequency and severe consequences of the development of AF and its association with LA size suggest that consideration should be given to preventing LA enlargement and to incorporating LA size in the clinical decision-making process in patients with MR.

AF in patients with MR

Atrial fibrillation is a common arrhythmia associated with an adverse prognosis (23). In the population, valvular disease is a risk factor for AF (4,6), but the incidence and implications of AF in specific valvular diseases remain uncertain. Such data are particularly important in MR because of the current high prevalence of MR (8) and of the uncertainties regarding the implications of AF in its management (13).

Although mild functional MR is common in primary AF (26), in MR due to organic valve diseases AF has been variably reported as rare (7,11) or relatively frequent (12) in small series that did not permit definition of determinants and outcome implications of AF. In the present study of patients with isolated pure degenerative MR due to MVP or flail leaflets, and who were conservatively managed after diagnosis in sinus rhythm, AF occurred frequently—in almost half the patients at 10 years, corresponding to a linearized rate of 5% per year. This rate includes permanent and paroxysmal AF, but combining these two forms is justified by previous reports and by our present data, suggesting that the prognosis of these two forms of AF may not be distinguishable (27).

Moreover, the high recurrence of AF after a first episode suggests that distinguishing paroxysmal from permanent AF is moot and that any AF should be considered a harbinger of clinical complications. Indeed, in the present series, we noted—to our knowledge for the first time—that the occurrence of AF in patients with MR is independently associated with an increased risk of death and heart failure under conservative management. After occurrence of AF, the risk of death or CHF more than doubles, even adjusting for baseline predictors of outcome. The grave prognosis of AF justifies defining the determinants of AF during follow-up.

Factors predisposing to AF in patients with MR

In the population, advancing age is linked with higher rates of AF (4,6,28). A link between AF and coronary disease has been suggested (29) but most often denied (3031), and this was not observed in our series. The mechanism by which aging influences the occurrence of AF remains unclear, but it may be related to structural or functional properties of atrial tissue (32). Nevertheless, AF is also frequent in younger patients with MR initially in sinus rhythm, occurring in almost one-fourth of them at 10 years and suggesting that other predisposing factors may lead to AF.

We observed a trend for slightly higher risk of AF in women. This trend, noted previously (6,33) although not consistently (34), was insignificant, particularly when gender differences in LA size were accounted for. Also, identical rates of AF were noted in MR due to flail leaflets and MVP, showing that AF is a complication of MR and not of a specific mitral lesion. Nevertheless, the lack of significant association between degree of MR and AF rate in patients with flail leaflet probably reflects a rapid progression of MR and of LA enlargement in these patients (35).

Thus, an important observation of this study is that LA enlargement is not a benign compensatory phenomenon in MR but leads to AF and its complications. A large atrial size has long been noted with chronic AF (36). However, this study demonstrates that in patients with degenerative MR in sinus rhythm at diagnosis, LA enlargement precedes and predisposes to the development of AF (45,9). Because AF seems to result from micro–re-entrant circuits (37), LA anatomic and electrical properties contribute to the arrhythmia (9). Left atrial enlargement preceding AF may be related to larger regurgitant volume (38) or to alterations of atrial myocardium (39), or to both, but in any case, LA dilation disturbs impulse propagation, leading to AF (5). Indeed, LA dimension remains independently predictive of AF, even after controlling for other markers of volume overload, such as LV size and function. Therefore, the clinical implications of these data should be considered.

Clinical implications

Occurrence of AF was independently related to excess mortality and morbidity under conservative management, in contrast to the fact that AF in asymptomatic patients with MR is labeled a class II indication for surgery (13). In view of the present results and the high maintenance of sinus rhythm if surgery is performed promptly after the onset of AF (40), it appears reasonable that recent onset of AF be considered a class I indication for surgery. Indications for the MAZE procedure (41) in MR with AF are not fully defined, but the relatively low additional risk of the atrial procedure suggests that such a combination can be considered (42).

Prevention of AF in MR is important. Prevention of LA enlargement has not yet been demonstrated. Early surgery appears to prevent cardiovascular morbidity (43) and may minimize complications related to marked LA enlargement (44), but its role in preventing AF is uncertain. The role of vasoactive treatment in MR has not been defined (13,45), but it may reduce LA size (46). In view of our data, clinical trials testing possible prevention of LA enlargement and AF in MR are needed.

Study limitations

Only AF demonstrated by electrocardiogram was considered. Thus, brief or unrecorded AF episodes may have been ignored. This approach, justified by potential misclassifications (6), was used in population studies of AF (56,9).

The echocardiographic diagnosis of flail leaflet (1617) and MVP (18) at different dates has become reliable and widely accepted and, therefore, the two populations are not totally simultaneous and their results are presented separately. Remarkably, the rates, predictors and impact of AF are identical, showing the robustness of the present data, which can be applied to all degenerative MR. For clinical outcome, a referral bias is often possible. However, in both uni- and multivariate analyses, AF rates were similar (p = 0.67 and p = 0.47) in community-based MVP and flail leaflet patients, and adjustment for comorbidity did not affect the results (p > 0.40), suggesting a low probability of referral bias.

The link between LA enlargement and subsequent AF may be questioned. However, LA size is also a marker of subsequent AF in the general population (56,9), of subsequent heart failure in MR (12), and even of subsequent mortality after surgery (47). Importantly, LA size normalized to BSA was a less powerful predictor of AF than was the absolute LA diameter or LA simply normalized to the mean by gender.

Conclusions

Patients with degenerative MR diagnosed in sinus rhythm, while under conservative management, incur subsequent AF frequently, in close to half of them at 10 years. The occurrence of AF is independently associated with a higher rate of subsequent adverse cardiac events. These findings suggest that prompt surgical consideration should be given to patients with severe MR in whom AF develops. Advancing age and LA enlargement at baseline are major predisposing factors for the development of AF. Therefore, the degree of LA enlargement, as a predictor of subsequent AF, should be taken into account when surgery is considered in patients with degenerative MR in sinus rhythm, and the possibility of preventing progression of LA enlargement should be evaluated in controlled trials in patients with MR.

Feinberg  W.M., Blackshear  J.L., Laupacis  A., Kronmal  R., Hart  R.G.; Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 155 1995:469-473.
CrossRef | PubMed
Wolf  P.A., Mitchell  J.B., Baker  C.S., Kannel  W.B., D’Agostino  R.B.; Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 158 1998:229-234.
CrossRef | PubMed
Benjamin  E.J., Wolf  P.A., D’Agostino  R.B., Silbershatz  H., Kannel  W.B., Levy  D.; Impact of atrial fibrillation on the risk of death. the Framingham Heart Study. Circulation. 98 1998:946-952.
CrossRef | PubMed
Psaty  B.M., Manolio  T.A., Kuller  L.H.; Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 96 1997:2455-2461.
CrossRef | PubMed
Vaziri  S.M., Larson  M.G., Benjamin  E.J., Levy  D.; Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 89 1994:724-730.
CrossRef | PubMed
Benjamin  E.J., Levy  D., Vaziri  S.M., D’Agostino  R.B., Belanger  A.J., Wolf  P.A.; Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 271 1994:840-844.
CrossRef | PubMed
Diker  E., Aydogdu  S., Ozdemir  M.; Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 77 1996:96-98.
CrossRef | PubMed
Singh  J.P., Evans  J.C., Levy  D.; Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 83 1999:897-902.
CrossRef | PubMed
Vasan  R.S., Larson  M.G., Levy  D., Evans  J.C., Benjamin  E.J.; Distribution and categorization of echocardiographic measurements in relation to reference limits. the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation. 96 1997:1863-1873.
CrossRef | PubMed
Tribouilloy  C.M., Enriquez-Sarano  M., Schaff  H.V.; Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation. rationale for optimizing surgical indications. Circulation. 99 1999:400-405.
CrossRef | PubMed
Stein  K.M., Borer  J.S., Hochreiter  C.; Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation. Circulation. 88 1993:127-135.
CrossRef | PubMed
Ling  L.H., Enriquez-Sarano  M., Seward  J.B.; Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 335 1996:1417-1423.
CrossRef | PubMed
Bonow  R.O., Carabello  B., de Leon  A.C.  Jr; Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). Circulation. 98 1998:1949-1984.
CrossRef | PubMed
Pearson  A.C., St. Vrain  J., Mrosek  D., Labovitz  A.J.; Color Doppler echocardiographic evaluation of patients with a flail mitral leaflet. J Am Coll Cardiol. 16 1990:232-239.
CrossRef | PubMed
Olson  L.J., Subramanian  R., Ackermann  D.M., Orszulak  T.A., Edwards  W.D.; Surgical pathology of the mitral valve. a study of 712 cases spanning 21 years. Mayo Clin Proc. 62 1987:22-34.
PubMed
Mintz  G.S., Kotler  M.N., Parry  W.R., Segal  B.L.; Statistical comparison of M-mode and two-dimensional echocardiographic diagnosis of flail mitral leaflets. Am J Cardiol. 45 1980:253-259.
CrossRef | PubMed
Enriquez-Sarano  M., Freeman  W.K., Tribouilloy  C.M.; Functional anatomy of mitral regurgitation. accuracy and outcome implications of transesophageal echocardiography. J Am Coll Cardiol. 34 1999:1129-1136.
CrossRef | PubMed
Levine  R.A., Stathogiannis  E., Newell  J.B., Harrigan  P., Weyman  A.E.; Reconsideration of echocardiographic standards for mitral valve prolapse. lack of association between leaflet displacement isolated to the apical four-chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 11 1988:1010-1019.
CrossRef | PubMed
Charlson  M.E., Pompei  P., Ales  K.L., MacKenzie  C.R.; A new method of classifying prognostic comorbidity in longitudinal studies. development and validation. J Chron Dis. 40 1987:373-383.
CrossRef | PubMed
Tajik  A.J., Seward  J.B., Hagler  D.J., Mair  D.D., Lie  J.T.; Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc. 53 1978:271-303.
PubMed
Mintz  G.S., Kotler  M.N., Segal  B.L., Parry  W.R.; Two-dimensional echocardiographic recognition of ruptured chordae tendineae. Circulation. 57 1978:244-250.
CrossRef | PubMed
Abbasi  A.S., Allen  M.W., DeCristofaro  D., Ungar  I.; Detection and estimation of the degree of mitral regurgitation by range-gated pulsed Doppler echocardiography. Circulation. 61 1980:143-147.
CrossRef | PubMed
Helmcke  F., Nanda  N.C., Hsiung  M.C.; Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 75 1987:175-183.
CrossRef | PubMed
Rich  S., Sheikh  A., Gallastegui  J., Kondos  G.T., Mason  T., Lam  W.; Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiography. Am Heart J. 104 1982:603-606.
CrossRef | PubMed
Quinones  M.A., Waggoner  A.D., Reduto  L.A.; A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 64 1981:744-753.
CrossRef | PubMed
Blackshear  J.L., Pearce  L.A., Asinger  R.W.; Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation investigators. Am J Cardiol. 72 1993:840-843.
CrossRef | PubMed
Aboaf  A.P., Wolf  P.S.; Paroxysmal atrial fibrillation. A common but neglected entity. Arch Intern Med. 156 1996:362-367.
CrossRef | PubMed
Phillips  S.J., Whisnant  J.P., O’Fallon  W.M., Frye  R.L.; Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc. 65 1990:344-359.
PubMed
Kitchin  A.H., Milne  J.S.; Longitudinal survey of ischaemic heart disease in randomly selected sample of older population. Br Heart J. 39 1977:889-893.
CrossRef | PubMed
Haddad  A.H., Prchkov  V.K., Dean  D.C.; Chronic atrial fibrillation and coronary artery disease. J Electrocardiol. 11 1978:67-69.
CrossRef | PubMed
Kannel  W.B., Abbott  R.D., Savage  D.D., McNamara  P.M.; Epidemiologic features of chronic atrial fibrillation. the Framingham Study. N Engl J Med. 306 1982:1018-1022.
CrossRef | PubMed
Cain  B.S., Meldrum  D.R., Joo  K.S.; Human SERCA2a levels correlate inversely with age in senescent human myocardium. J Am Coll Cardiol. 32 1998:458-467.
CrossRef | PubMed
Onundarson  P.T., Thorgeirsson  G., Jonmundsson  E., Sigfusson  N., Hardarson  T.; Chronic atrial fibrillation—epidemiologic features and 14-year follow-up. a case control study. Eur Heart J. 8 1987:521-527.
PubMed
Davidson  E., Weinberger  I., Rotenberg  Z., Fuchs  J., Agmon  J.; Atrial fibrillation. Cause and time of onset. Arch Intern Med. 149 1989:457-459.
CrossRef | PubMed
Enriquez-Sarano  M., Basmadjian  A.J., Rossi  A., Bailey  K.R., Seward  J.B., Tajik  A.J.; Progression of mitral regurgitation. a prospective Doppler echocardiographic study. J Am Coll Cardiol. 34 1999:1137-1144.
CrossRef | PubMed
Dittrich  H.C., Pearce  L.A., Asinger  R.W.;Stroke Prevention in Atrial Fibrillation investigators Left atrial diameter in nonvalvular atrial fibrillation. An echocardiographic study. Am Heart J. 137 1999:494-499.
CrossRef | PubMed
Alessie  M., Rensma  P., Brugada  J., Smeets  J., Penn  O., Kirchhof  C.; Pathophysiology of atrial fibrillation.Zipes  D.P., Jalife  J.; Cardiac Electrophysiology: From Cell to Bedside. 1990 WB Saunders Philadelphia, PA:548-559.
Enriquez-Sarano  M., Seward  J.B., Bailey  K.R., Tajik  A.J.; Effective regurgitant orifice area. a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol. 23 1994:443-451.
CrossRef | PubMed
Frustaci  A., Chimenti  C., Bellocci  F., Morgante  E., Russo  M.A., Maseri  A.; Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 96 1997:1180-1184.
CrossRef | PubMed
Chua  Y.L., Schaff  H.V., Orszulak  T.A., Morris  J.J.; Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty?. J Thorac Cardiovasc Surg. 107 1994:408-415.
PubMed
Cox  J.L., Sundt  T.M.  III; The surgical management of atrial fibrillation. Annu Rev Med. 48 1997:511-523.
CrossRef | PubMed
Handa  N., Schaff  H.V., Morris  J.J., Anderson  B.J., Kopecky  S.L., Enriquez-Sarano  M.; Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg. 118 1999:628-635.
CrossRef | PubMed
Ling  L.H., Enriquez-Sarano  M., Seward  J.B.; Early surgery in patients with mitral regurgitation due to flail leaflets. a long-term outcome study. Circulation. 96 1997:1819-1825.
CrossRef | PubMed
Reed  D., Smucker  M.L., Kaul  S.; Why is left atrial size an important determinant of outcome after mitral valve replacement in patients with chronic mitral regurgitation?. (abstr) Clin Res. 39 1991:370A
Levine  H.J., Gaasch  W.H.; Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol. 28 1996:1083-1091.
CrossRef | PubMed
Dujardin  K.S., Enriquez-Sarano  M., Bailey  K.R., Seward  J.B., Tajik  A.J.; Effect of losartan on degree of mitral regurgitation quantified by echocardiography. Am J Cardiol. 87 2001:570-576.
CrossRef | PubMed
Reed  D., Abbott  R.D., Smucker  M.L., Kaul  S.; Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size. Circulation. 84 1991:23-34.
CrossRef | PubMed

Figures

Grahic Jump Location
Figure 1

Incidence of atrial fibrillation (AFib) under conservative (medical) management among patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm. The overall rates of new atrial fibrillation and of permanent and paroxysmal atrial fibrillation are presented as Kaplan-Meier curves.

Grahic Jump Location
Figure 2

Atrial fibrillation (AFib) rate in patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm, according to age at diagnosis, <65 or ≥65 years old (yo). Note the considerably higher rate in older patients.

Grahic Jump Location
Figure 3

Atrial fibrillation (AFib) rate in patients with mitral regurgitation due to flail leaflets diagnosed with the patient in sinus rhythm, according to left atrial diameter at diagnosis <50 or ≥50 mm. Note the considerably higher rate in patients with a markedly dilated left atrium.

Grahic Jump Location
Figure 4

Survival of patients with mitral regurgitation due to flail leaflets adjusted for age, gender, ejection fraction and symptoms at baseline, and separating at the fourth year after diagnosis those patients with and those without postdiagnosis atrial fibrillation. Note the excess mortality in patients with follow-up atrial fibrillation. SR = sinus rhythm; AF = atrial fibrillation; F-U = follow-up.

Tables

Table Grahic Jump Location
Table 1Baseline Characteristics of Patients With MR Due to Flail Leaflets and Association With Subsequent Development of AF
Table Footer Note*Denotes p < 0.05 in comparison with patients in whom AF developed under conservative management.
Table Footer NoteTime to AF is for events occurring under conservative management. Continuous variables are expressed as mean ± SD and categorical variables as percentages.
Table Grahic Jump Location
Table 2Multivariate Predictors of Atrial Fibrillation

Interactive Graphics

Video

References

Feinberg  W.M., Blackshear  J.L., Laupacis  A., Kronmal  R., Hart  R.G.; Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications. Arch Intern Med. 155 1995:469-473.
CrossRef | PubMed
Wolf  P.A., Mitchell  J.B., Baker  C.S., Kannel  W.B., D’Agostino  R.B.; Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med. 158 1998:229-234.
CrossRef | PubMed
Benjamin  E.J., Wolf  P.A., D’Agostino  R.B., Silbershatz  H., Kannel  W.B., Levy  D.; Impact of atrial fibrillation on the risk of death. the Framingham Heart Study. Circulation. 98 1998:946-952.
CrossRef | PubMed
Psaty  B.M., Manolio  T.A., Kuller  L.H.; Incidence of and risk factors for atrial fibrillation in older adults. Circulation. 96 1997:2455-2461.
CrossRef | PubMed
Vaziri  S.M., Larson  M.G., Benjamin  E.J., Levy  D.; Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation. 89 1994:724-730.
CrossRef | PubMed
Benjamin  E.J., Levy  D., Vaziri  S.M., D’Agostino  R.B., Belanger  A.J., Wolf  P.A.; Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA. 271 1994:840-844.
CrossRef | PubMed
Diker  E., Aydogdu  S., Ozdemir  M.; Prevalence and predictors of atrial fibrillation in rheumatic valvular heart disease. Am J Cardiol. 77 1996:96-98.
CrossRef | PubMed
Singh  J.P., Evans  J.C., Levy  D.; Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 83 1999:897-902.
CrossRef | PubMed
Vasan  R.S., Larson  M.G., Levy  D., Evans  J.C., Benjamin  E.J.; Distribution and categorization of echocardiographic measurements in relation to reference limits. the Framingham Heart Study: formulation of a height- and sex-specific classification and its prospective validation. Circulation. 96 1997:1863-1873.
CrossRef | PubMed
Tribouilloy  C.M., Enriquez-Sarano  M., Schaff  H.V.; Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation. rationale for optimizing surgical indications. Circulation. 99 1999:400-405.
CrossRef | PubMed
Stein  K.M., Borer  J.S., Hochreiter  C.; Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation. Circulation. 88 1993:127-135.
CrossRef | PubMed
Ling  L.H., Enriquez-Sarano  M., Seward  J.B.; Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med. 335 1996:1417-1423.
CrossRef | PubMed
Bonow  R.O., Carabello  B., de Leon  A.C.  Jr; Guidelines for the management of patients with valvular heart disease: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Valvular Heart Disease). Circulation. 98 1998:1949-1984.
CrossRef | PubMed
Pearson  A.C., St. Vrain  J., Mrosek  D., Labovitz  A.J.; Color Doppler echocardiographic evaluation of patients with a flail mitral leaflet. J Am Coll Cardiol. 16 1990:232-239.
CrossRef | PubMed
Olson  L.J., Subramanian  R., Ackermann  D.M., Orszulak  T.A., Edwards  W.D.; Surgical pathology of the mitral valve. a study of 712 cases spanning 21 years. Mayo Clin Proc. 62 1987:22-34.
PubMed
Mintz  G.S., Kotler  M.N., Parry  W.R., Segal  B.L.; Statistical comparison of M-mode and two-dimensional echocardiographic diagnosis of flail mitral leaflets. Am J Cardiol. 45 1980:253-259.
CrossRef | PubMed
Enriquez-Sarano  M., Freeman  W.K., Tribouilloy  C.M.; Functional anatomy of mitral regurgitation. accuracy and outcome implications of transesophageal echocardiography. J Am Coll Cardiol. 34 1999:1129-1136.
CrossRef | PubMed
Levine  R.A., Stathogiannis  E., Newell  J.B., Harrigan  P., Weyman  A.E.; Reconsideration of echocardiographic standards for mitral valve prolapse. lack of association between leaflet displacement isolated to the apical four-chamber view and independent echocardiographic evidence of abnormality. J Am Coll Cardiol. 11 1988:1010-1019.
CrossRef | PubMed
Charlson  M.E., Pompei  P., Ales  K.L., MacKenzie  C.R.; A new method of classifying prognostic comorbidity in longitudinal studies. development and validation. J Chron Dis. 40 1987:373-383.
CrossRef | PubMed
Tajik  A.J., Seward  J.B., Hagler  D.J., Mair  D.D., Lie  J.T.; Two-dimensional real-time ultrasonic imaging of the heart and great vessels. Technique, image orientation, structure identification, and validation. Mayo Clin Proc. 53 1978:271-303.
PubMed
Mintz  G.S., Kotler  M.N., Segal  B.L., Parry  W.R.; Two-dimensional echocardiographic recognition of ruptured chordae tendineae. Circulation. 57 1978:244-250.
CrossRef | PubMed
Abbasi  A.S., Allen  M.W., DeCristofaro  D., Ungar  I.; Detection and estimation of the degree of mitral regurgitation by range-gated pulsed Doppler echocardiography. Circulation. 61 1980:143-147.
CrossRef | PubMed
Helmcke  F., Nanda  N.C., Hsiung  M.C.; Color Doppler assessment of mitral regurgitation with orthogonal planes. Circulation. 75 1987:175-183.
CrossRef | PubMed
Rich  S., Sheikh  A., Gallastegui  J., Kondos  G.T., Mason  T., Lam  W.; Determination of left ventricular ejection fraction by visual estimation during real-time two-dimensional echocardiography. Am Heart J. 104 1982:603-606.
CrossRef | PubMed
Quinones  M.A., Waggoner  A.D., Reduto  L.A.; A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography. Circulation. 64 1981:744-753.
CrossRef | PubMed
Blackshear  J.L., Pearce  L.A., Asinger  R.W.; Mitral regurgitation associated with reduced thromboembolic events in high-risk patients with nonrheumatic atrial fibrillation. Stroke Prevention in Atrial Fibrillation investigators. Am J Cardiol. 72 1993:840-843.
CrossRef | PubMed
Aboaf  A.P., Wolf  P.S.; Paroxysmal atrial fibrillation. A common but neglected entity. Arch Intern Med. 156 1996:362-367.
CrossRef | PubMed
Phillips  S.J., Whisnant  J.P., O’Fallon  W.M., Frye  R.L.; Prevalence of cardiovascular disease and diabetes mellitus in residents of Rochester, Minnesota. Mayo Clin Proc. 65 1990:344-359.
PubMed
Kitchin  A.H., Milne  J.S.; Longitudinal survey of ischaemic heart disease in randomly selected sample of older population. Br Heart J. 39 1977:889-893.
CrossRef | PubMed
Haddad  A.H., Prchkov  V.K., Dean  D.C.; Chronic atrial fibrillation and coronary artery disease. J Electrocardiol. 11 1978:67-69.
CrossRef | PubMed
Kannel  W.B., Abbott  R.D., Savage  D.D., McNamara  P.M.; Epidemiologic features of chronic atrial fibrillation. the Framingham Study. N Engl J Med. 306 1982:1018-1022.
CrossRef | PubMed
Cain  B.S., Meldrum  D.R., Joo  K.S.; Human SERCA2a levels correlate inversely with age in senescent human myocardium. J Am Coll Cardiol. 32 1998:458-467.
CrossRef | PubMed
Onundarson  P.T., Thorgeirsson  G., Jonmundsson  E., Sigfusson  N., Hardarson  T.; Chronic atrial fibrillation—epidemiologic features and 14-year follow-up. a case control study. Eur Heart J. 8 1987:521-527.
PubMed
Davidson  E., Weinberger  I., Rotenberg  Z., Fuchs  J., Agmon  J.; Atrial fibrillation. Cause and time of onset. Arch Intern Med. 149 1989:457-459.
CrossRef | PubMed
Enriquez-Sarano  M., Basmadjian  A.J., Rossi  A., Bailey  K.R., Seward  J.B., Tajik  A.J.; Progression of mitral regurgitation. a prospective Doppler echocardiographic study. J Am Coll Cardiol. 34 1999:1137-1144.
CrossRef | PubMed
Dittrich  H.C., Pearce  L.A., Asinger  R.W.;Stroke Prevention in Atrial Fibrillation investigators Left atrial diameter in nonvalvular atrial fibrillation. An echocardiographic study. Am Heart J. 137 1999:494-499.
CrossRef | PubMed
Alessie  M., Rensma  P., Brugada  J., Smeets  J., Penn  O., Kirchhof  C.; Pathophysiology of atrial fibrillation.Zipes  D.P., Jalife  J.; Cardiac Electrophysiology: From Cell to Bedside. 1990 WB Saunders Philadelphia, PA:548-559.
Enriquez-Sarano  M., Seward  J.B., Bailey  K.R., Tajik  A.J.; Effective regurgitant orifice area. a noninvasive Doppler development of an old hemodynamic concept. J Am Coll Cardiol. 23 1994:443-451.
CrossRef | PubMed
Frustaci  A., Chimenti  C., Bellocci  F., Morgante  E., Russo  M.A., Maseri  A.; Histological substrate of atrial biopsies in patients with lone atrial fibrillation. Circulation. 96 1997:1180-1184.
CrossRef | PubMed
Chua  Y.L., Schaff  H.V., Orszulak  T.A., Morris  J.J.; Outcome of mitral valve repair in patients with preoperative atrial fibrillation. Should the maze procedure be combined with mitral valvuloplasty?. J Thorac Cardiovasc Surg. 107 1994:408-415.
PubMed
Cox  J.L., Sundt  T.M.  III; The surgical management of atrial fibrillation. Annu Rev Med. 48 1997:511-523.
CrossRef | PubMed
Handa  N., Schaff  H.V., Morris  J.J., Anderson  B.J., Kopecky  S.L., Enriquez-Sarano  M.; Outcome of valve repair and the Cox maze procedure for mitral regurgitation and associated atrial fibrillation. J Thorac Cardiovasc Surg. 118 1999:628-635.
CrossRef | PubMed
Ling  L.H., Enriquez-Sarano  M., Seward  J.B.; Early surgery in patients with mitral regurgitation due to flail leaflets. a long-term outcome study. Circulation. 96 1997:1819-1825.
CrossRef | PubMed
Reed  D., Smucker  M.L., Kaul  S.; Why is left atrial size an important determinant of outcome after mitral valve replacement in patients with chronic mitral regurgitation?. (abstr) Clin Res. 39 1991:370A
Levine  H.J., Gaasch  W.H.; Vasoactive drugs in chronic regurgitant lesions of the mitral and aortic valves. J Am Coll Cardiol. 28 1996:1083-1091.
CrossRef | PubMed
Dujardin  K.S., Enriquez-Sarano  M., Bailey  K.R., Seward  J.B., Tajik  A.J.; Effect of losartan on degree of mitral regurgitation quantified by echocardiography. Am J Cardiol. 87 2001:570-576.
CrossRef | PubMed
Reed  D., Abbott  R.D., Smucker  M.L., Kaul  S.; Prediction of outcome after mitral valve replacement in patients with symptomatic chronic mitral regurgitation. The importance of left atrial size. Circulation. 84 1991:23-34.
CrossRef | PubMed

Correspondence

Latest JACC CME

Continuing Medical Education through JACC is a convenient way to fulfill your CME requirements while learning important information about the latest advances in cardiovascular medicine.

April 2013- JACC CME Activity
Repeat Revascularization and Outcome

March 2013- JACC CME Activity
Extreme Lipoprotein(a) Levels and Improved Cardiovascular Risk Prediction

Feb 2013- JACC CME Activity
Results from the BARI 2D Trial

Jan 2013- JACC CME Activity
Prognosis Among Healthy Individuals Discharged With a Primary Diagnosis of Syncope

Dec 2012- JACC CME Activity
Incidence of Heart Failure or Cardiomyopathy After Adjuvant Trastuzumab Therapy for Breast Cancer

Nov 2012- JACC CME Activity
A Collaborative Analysis of Individual Patient Data From 10 Randomized Trials

Oct 2012- JACC CME Activity
Radiofrequency Ablation of Premature Ventricular Ectopy Improves the Efficacy of Cardiac Resynchronization Therapy in Nonresponders

Sept 2012- JACC CME Activity
Exercise and Pharmacological Treatment of Depressive Symptoms in Patients With Coronary Heart Disease

Aug 2012- JACC CME Activity
Reduction in Life-Threatening Ventricular Tachyarrhythmias in Statin-Treated Patients With Nonischemic Cardiomyopathy Enrolled in the MADIT-CRT (Multicenter Automatic Defibrillator Implantation Trial with Cardiac Resynchronization Therapy)

July 2012- JACC CME Activity
Relationship of Beta-Blocker Dose With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction

For previous CME quizzes, please follow this link to CardioSource Lifelong Learning and MOC.

 

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Topics
PubMed Articles